IGF2BP1

IGF2BP1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IGF2BP1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>IGF2BP1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Insulin-Like Growth Factor 2 mRNA-Binding Protein 1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>IMP1, CRD-BP, ZBP1 (Zinc Finger Protein 36-Like 1)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17q21.32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[10682](https://www.ncbi.nlm.nih.gov/gene/10682)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[608288](https://www.omim.org/entry/608288)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000159248</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9Y296](https://www.uniprot.org/uniprot/Q9Y296)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">172 edges</a></td>
</tr>
</table>

IGF2BP1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IGF2BP1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>IGF2BP1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Insulin-Like Growth Factor 2 mRNA-Binding Protein 1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>IMP1, CRD-BP, ZBP1 (Zinc Finger Protein 36-Like 1)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17q21.32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[10682](https://www.ncbi.nlm.nih.gov/gene/10682)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[608288](https://www.omim.org/entry/608288)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000159248</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9Y296](https://www.uniprot.org/uniprot/Q9Y296)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">172 edges</a></td>
</tr>
</table>

IGF2BP1 (Insulin-Like Growth Factor 2 mRNA-Binding Protein 1), also known as IMP1 (IGF2 mRNA-Binding Protein 1) or CRD-BP (Coding Region Determinant-Binding Protein), is a member of the IMP family of RNA-binding proteins. These proteins are characterized by six conserved KH (hnRNP K Homology) domains that enable sequence-specific RNA binding. IGF2BP1 plays critical roles in embryonic development, neuronal differentiation, synaptic plasticity, and cellular stress responses. In the context of neurodegenerative diseases, IGF2BP1 has emerged as an important regulator of RNA metabolism, with connections to amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease (AD). The protein localizes to stress granules under cellular stress conditions, and dysregulation of IGF2BP1 function contributes to the RNA metabolism defects observed in these disorders. This comprehensive review covers IGF2BP1's molecular biology, function in the nervous system, disease associations, and therapeutic implications.

Gene and Protein Structure

Gene Organization

The IGF2BP1 gene (Official Symbol: IGF2BP1; HGNC: 20668) is located on chromosome 17q21.32 and spans approximately 25 kilobases. The gene consists of 17 exons encoding a protein of 660 amino acids with a molecular weight of approximately 75 kDa.

Gene Information Table:

Protein Domains

IGF2BP1 contains six KH domains arranged in four clusters, along with several auxiliary regions:

The KH domain structure allows IGF2BP1 to bind both single-stranded and structured RNA sequences with high specificity. The protein can recognize RNA elements in both 3' untranslated regions (3' UTRs) and coding regions, enabling diverse regulatory functions.

Molecular Function

RNA Binding and Regulation

IGF2BP1 regulates RNA metabolism through multiple mechanisms:

mRNA Localization:

• IGF2BP1 binds to specific sequences in target mRNAs, often located in 3' UTRs
• The protein forms ribonucleoprotein (RNP) particles that are transported along cytoskeletal filaments (microtubules) to specific subcellular locations
• Key transported mRNAs include those encoding proteins involved in synaptic function, axonal extension, and neuronal differentiation

• IGF2BP1 protects target mRNAs from degradation by shielding them from exonucleases
• The protein recruits deadenylation complexes and can either stabilize or destabilize transcripts depending on cellular context
• Under stress conditions, IGF2BP1-mediated stabilization can be altered

• IGF2BP1 can both stimulate and repress translation of target mRNAs
• Under cellular stress, IGF2BP1 associates with stress granules and translation is inhibited
• The protein interacts with the translation initiation machinery and can modulate eIF4E availability

Stress Granule Formation

IGF2BP1 is a key component of stress granules (SGs), membrane-less organelles that form in response to various cellular stresses:

Stress Granule Biology:

• Stress granules form when translation initiation is inhibited (e.g., due to eIF2α phosphorylation)
• IGF2BP1 rapidly localizes to stress granules through its KH domains and glycine-rich region
• The protein remains in stress granules until stress is resolved or phases into larger aggregates

• Temporarily sequester mRNAs and RNA-binding proteins during stress
• Protect mRNAs from degradation
• Enable selective translation of stress-response proteins

• Persistent or dysregulated stress granule formation is observed in ALS, AD, and PD
• Mutations in stress granule components (including TDP-43, FUS, G3BP1) cause familial ALS
• IGF2BP1's role in stress granule dynamics connects it to these disease mechanisms

Cellular Localization

In neurons, IGF2BP1 localizes to:

• Dendrites: The protein is transported into dendritic processes in RNA granules
• Axons: IGF2BP1-positive granules are present in axons, enabling axonal RNA localization
• Neuronal Soma: Cytoplasmic localization with nuclear export capability
• Synaptic Regions: Local translation at dendritic spines is regulated by IGF2BP1

Expression Pattern

Developmental Expression

IGF2BP1 exhibits stage-specific expression:

• Embryonic Development: High expression in embryonic tissues including brain, with roles in neural tube formation and neuronal differentiation
• Postnatal Brain: Expression decreases in most brain regions but persists in specific populations
• Adult Brain: Lower expression in most regions compared to development, with specific enrichment in neurogenic zones

Brain Expression

In the adult brain, IGF2BP1 is expressed in:

• Hippocampus: Particularly in CA1 and CA3 regions, with expression in pyramidal neurons
• Cerebral Cortex: Layer 2/3 pyramidal neurons and interneurons
• Cerebellum: Purkinje cells and granule cells
• Olfactory Bulb: Subventricular zone neural progenitors

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

IGF2BP1 is strongly implicated in ALS pathogenesis:

Stress Granule Dynamics:

• IGF2BP1 rapidly localizes to stress granules in response to cellular stress [@igf2bp1Stress2020]
• ALS-linked mutations in TDP-43, FUS, and C9orf72 alter stress granule composition and dynamics
• IGF2BP1 remains in stress granules longer in ALS models, potentially contributing to translational blockade

• ALS is characterized by widespread RNA metabolism defects
• IGF2BP1 regulates numerous mRNAs involved in neuronal survival
• Loss of IGF2BP1 function may contribute to axonal degeneration

• Modulating stress granule dynamics represents a therapeutic strategy
• Enhancing IGF2BP1-mediated RNA transport may restore neuronal function

Alzheimer's Disease

IGF2BP1 alterations are observed in AD brain:

Expression Changes:

• IGF2BP1 expression is altered in AD brain, particularly in affected regions [@igf2bp1AD2022]
• The protein localizes to dystrophic neurites surrounding amyloid plaques
• Tau pathology affects IGF2BP1 distribution and function

• Amyloid-β oligomers induce stress granule formation, sequestering IGF2BP1
• Chronic stress granule formation may contribute to translational deficits in AD
• IGF2BP1 dysfunction may impair local translation at synapses

Parkinson's Disease

IGF2BP1 connections to PD include:

Stress Response:

• PD-linked proteins (alpha-synuclein, LRRK2, parkin) affect cellular stress responses
• IGF2BP1-mediated stress granule formation is altered in PD models
• Mitochondrial dysfunction in PD may trigger IGF2BP1 redistribution

• Axonal transport defects are an early feature of PD
• IGF2BP1-dependent RNA transport may be impaired in dopaminergic neurons
• Restoring RNA transport could represent a therapeutic approach

Protein-Protein Interactions

IGF2BP1 interacts with numerous proteins involved in RNA metabolism:

RNA-Binding Proteins

• TDP-43 (TARDBP): Major ALS disease protein, shares stress granule localization
• FUS: Another ALS disease protein, interacts in stress granules
• G3BP1: Stress granule marker and assembly factor

Transport Machinery

• Transportin-1 (TNPO1): Mediates nuclear import of IGF2BP1
• KIF5: Kinesin motor that transports IGF2BP1-positive granules along microtubules
• hnRNP A1: Co-transport with IGF2BP1 in neuronal granules

Translation Factors

• eIF4E: Cap-binding protein, competition affects translation initiation
• PABP1: Poly(A)-binding protein, interacts in stress granules

Animal Models

Knockout Studies

Igf2bp1 Knockout Mice:

• Knockout mice are viable but show developmental defects
• Altered neuronal migration and axon guidance
• Impaired synaptic plasticity and behavior

Transgenic Models

• IGF2BP1 overexpression in neurons enhances RNA transport
• ALS-linked mutations in stress granule proteins alter IGF2BP1 dynamics

Therapeutic Implications

Drug Development

Therapeutic strategies targeting IGF2BP1 include:

Biomarker Potential

IGF2BP1-related biomarkers include:

• CSF IGF2BP1 levels as indicators of neuronal stress
• Peripheral blood monocyte IGF2BP1 expression
• Stress granule markers as surrogate endpoints

Research Directions

Emerging Questions

Future Studies

• Single-cell analysis of IGF2BP1 in neurodegenerative disease brain
• Development of brain-penetrant stress granule modulators
• CRISPR-based approaches to modulate IGF2BP1 function

Cross-Links

Related Proteins

• [TARDBP (TDP-43)](/genes/tardbp)
• [FUS](/genes/fus)
• [G3BP1](/entities/g3bp1)

Related Mechanisms

• [Stress Granules](/mechanisms/stress-granules)
• [RNA Metabolism in Neurodegeneration](/mechanisms/rna-metabolism)
• [Synaptic RNA Localization](/mechanisms/synaptic-rna-localization)
• [Axonal Transport](/mechanisms/axonal-transport)

Related Diseases

• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

Brain Atlas Resources

• [Allen Human Brain Atlas - IGF2BP1](https://human.brain-map.org/microarray/search/show?search_term=IGF2BP1)
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/)
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/)

References

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Mechanisms Index](/mechanisms)
• [ALS Gene Overview](/diseases/amyotrophic-lateral-sclerosis)

Pathway Diagram

The following diagram shows the key molecular relationships involving IGF2BP1 discovered through SciDEX knowledge graph analysis:

Pathway Diagram

The following diagram shows the key molecular relationships involving IGF2BP1 discovered through SciDEX knowledge graph analysis: